QT:{{”
Richard – Absolutely correct. That’s exactly what we did. We designed a study using a treatment called benralizumab. Benralizumab is an antibody therapy given by injection which specifically targets eosinophil production and migration into the lungs. We compared this with standard therapy oral corticosteroids, and indeed we had a third arm, which was a combination of the two treatments together. “}}
Posts Tagged ‘keyabbrev’
Jab to alleviate asthma attacks, and amber in Antarctica | Podcasts
December 22, 2024Do you drink coffee? Ask your gut
December 22, 2024https://www.nature.com/articles/d41586-024-03866-5
QT:{{”
One particular gut microbe is quite the coffee fiend. Lawsonibacter asaccharolyticus was up to eight times more abundant in coffee drinkers than in non-drinkers. In a culture dish, the bacteria grew faster when fed coffee of any kind — brewed or instant, caffeinated or decaffeinated — than when fed no coffee.
“}}
How a new kind of vaccine could lead to the eradication of Alzheimer’s and dementia | New Scientist
November 10, 2024Physics-Informed Neural Networks: An Application-Centric Guide | by Shuai Guo | Towards Data Science
November 2, 2024The battle over the trillion-dollar weight-loss bonanza
October 4, 2024https://www.economist.com/business/2024/03/04/the-battle-over-the-trillion-dollar-weight-loss-bonanza glp-1 agonists
QT:{{”
The drugs’ biggest impact so far, though, has been on their makers. Sales of Wegovy, developed by a Danish firm called Novo Nordisk, swelled from $876m in 2022 to $4.5bn in 2023. The company expects double that this year. Zepbound, introduced in America in November by Eli Lilly, an American pharma giant, is expected to generate $2.9bn in sales in its first full year. Bloomberg, a data provider, predicts that by 2030 yearly sales of weight-loss medications will reach a staggering $80bn, putting them among the biggest classes of drugs in history. Eli Lilly and Novo Nordisk are expected to corner more than 90% of the market (see chart 2).
“}}
How 3M Discovered, Then Concealed, the Dangers of Forever Chemicals | The New Yorker
August 27, 2024https://www.newyorker.com/magazine/2024/05/27/3m-forever-chemicals-pfas-pfos-toxic
Lerner, S. (2024, May 20). How 3M discovered, then concealed, the dangers of forever chemicals. The New Yorker.
https://www.newyorker.com/magazine/2024/05/27/3m-forever-chemicals-pfas-pfos-toxic
the horror of PFOS
Golden ratio – Wikipedia
May 2, 2024https://en.wikipedia.org/wiki/Golden_ratio
1.618033988749
Adjusted EBITDA Example | A Simple Model
March 12, 2024Has Alzheimer’s met its match? – ScienceDirect
February 29, 2024https://www.sciencedirect.com/science/article/abs/pii/S0262407923009429?via%3Dihub
New Scientist
Volume 258, Issue 3440, 27 May 2023, Pages 14-15
Has Alzheimer’s met its match?
Clare Wilson
